MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on November 13, 2015. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 13, 2015. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
Serum proteomics in multiple sclerosis disease progression.
Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis.
Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.
Interferon-beta and disability progression in relapsing-remitting multiple sclerosis.
The onset and progression of the lesion in multiple sclerosis.
Genetic determinants of risk and progression in multiple sclerosis.
Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
Serum NSE level and disability progression in multiple sclerosis.
Multiple sclerosis: clinical characteristics and disability progression in Moroccan children.
Pyk2 promotes tumor progression in multiple myeloma.
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!
Multiple sclerosis disease progression and paradichlorobenzene: a tale of mothballs and toilet cleaner.
Multiple sclerosis and Hodgkin's disease in Denmark.
A longitudinal model for disease progression was developed and applied to multiple sclerosis.
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.
The Role of Astrocytes in Multiple Sclerosis Progression.
Challenges in multiple sclerosis; how to define occurence of progression.
Tumor necrosis factor-alpha and interferon-gamma synthesis by cerebrospinal fluid-derived T cell clones in multiple sclerosis.
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
Tumor necrosis factor-alpha and disease progression in multiple sclerosis.
The New England Journal of Medicine Downloaded from nejm.org on November 13, 2015. For personal use only. No other uses without permission. Copyright...
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
Serum proteomics in multiple sclerosis disease progression.
Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis.
Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.
Interferon-beta and disability progression in relapsing-remitting multiple sclerosis.
The onset and progression of the lesion in multiple sclerosis.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms